Xtalks

2 weeks ago | xtalks.com | Ayesha Rashid

In this episode, Ayesha speaks with Ebrahim S. Delpassand, MD, Founder and CEO of RadioMedix, a company developing innovative radiopharmaceuticals for cancer diagnosis, monitoring and treatment. With a focus on both PET imaging and therapeutic radiopharmaceuticals labeled with alpha and beta emitters, RadioMedix is helping to shape the future of precision oncology. Dr. Delpassand brings a wealth of expertise as a board-certified nuclear medicine physician and a seasoned healthcare entrepreneur.

2 weeks ago | xtalks.com | Vera Kovacevic

Diabetes affects hundreds of millions worldwide — currently, about 537 million people live with the condition, with projections reaching nearly 643 million by 2030. These figures underline the urgency for novel and more effective treatment strategies, particularly for type 1 diabetes (T1D). Although T1D accounts for only about 5% to 10% of all diabetes cases, its onset at a young age and the need for lifelong management present unique challenges.

3 weeks ago | xtalks.com | Vera Kovacevic

Digital health is reshaping clinical research and care delivery by offering more comprehensive insights into patient health. In traditional clinical trials, endpoints — measurable outcomes such as lab results, imaging studies or clinical assessments — are collected during scheduled visits at the clinic. In contrast, digital endpoints are derived from data captured continuously or intermittently through digital health technologies (DHTs), often outside of a clinical setting.

3 weeks ago | xtalks.com | Ayesha Rashid

In this episode, Ayesha speaks with Norman Putzki, MD, Senior Vice President and Global Development Head of Neuroscience and Gene Therapy at Novartis, about the complexities and real-world challenges of bringing new therapies to patients with neurological diseases. Dr. Putzki discusses the challenges and opportunities in developing treatments for complex brain disorders, and how gene therapy is being applied in neurological disease.

3 weeks ago | xtalks.com | Ayesha Rashid

US president Donald Trump has unveiled his fiscal year 2026 budget proposal, introducing sweeping healthcare cuts and while significantly increasing defense and border security spending. The proposal, released on May 2, 2025, outlines a $163 billion cut to non-defense discretionary spending — a 23% reduction from 2025 levels — marking one of the most substantial overhauls of the federal budget in recent history.